International Congress on Targeted Anticancer Therapies

"Early phase cancer drugs development"
The TAT Congress has firmly established itself as the must-attend forum for all experts focusing on early phase drug development and translational research.Stakeholders from academia and industry meet with clinicians, researchers and regulators from all around the world to facilitate the development of new anti-cancer treatments and make more options available to patients. The TAT Congress series has effectively transformed the landscape of early drug development and you have the opportunity to be a part of a highly influential meeting.Participating in TAT 2020 will bring you outstanding networking opportunities, enlightening discussions and promising new partnerships.We hope to see you at TAT 2020!

Highlights

• Genomic tumour boards
• Preclinical studies for identifying key drug combinations
• Microbiome studies: Moving beyond immunotherapy
• Targeting and targeted cytokines
• Oncolytic Viruses

User Reviews

5
06 Mar 2019

Aso hamakaram hassan Media Consultant at medical Sulaymaniyah, Iraq

---

2
29 Apr 2017

Hiba Hussein Individual Baghdad, Iraq

---